Press release
Kidney Cancer Drugs 2017 Global Market Expected to Grow at CAGR 7.36% and Forecast to 2019
Kidney Cancer Market 2017About Kidney Cancer
Kidney cancer also known as renal cancer affects the kidney cells. RCC is the most common form of kidney cancer in adults and Wilms' tumor in children. The exact cause of the disease is not yet known. The symptoms of renal cancer are often confused with other kidney disorders. This usually results in late stage detection of the disease, which leads to less chances of patient survival. In the majority of cases, it is diagnosed accidentally, when the patient undergoes checkups for other disorders.
Kidney cancer can be triggered by a number of factors including both lifestyle-related changes and genetic changes. The surgical removal of affected cancerous cells from the kidney provides a complete cure of the disease. A number of drugs are also available, which also help in the treatment of the disease when it is diagnosed at earlier stages.
Technavio's analysts forecast the global kidney cancer drugs market to grow at a CAGR of 7.36% over the period 2014-2019.
Request For Sample Report @ https://www.wiseguyreports.com/sample-request/69824-global-kidney-cancer-drugs-market-2015-2019
Covered in this Report
The report covers the present scenario and the growth prospects of the global kidney cancer drugs market for 2015-2019. To calculate the market size, the report considers the revenue generated from the sales of various approved therapies and off-label drugs used for the treatment of kidney cancer.
The three regions covered in the report are as follows:
• Americas: US, Canada, Mexico, and Brazil
• EMEA: UK, Germany, Italy, France, and Spain and Middle Eastern and African countries such Israel, South Africa, Egypt, Sudan, Kuwait, Saudi Arabia, Qatar, and UAE
• APAC: Japan, China, Australia, Singapore, South Korea, and India.
Technavio's report, Global Kidney Cancer Drugs Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key Regions
• Americas
• APAC
• EMEA
Key Vendors
• Bayer
• F. Hoffmann-La Roche
• GlaxoSmithKline
• Novartis
• Pfizer
Other Prominent Vendors
• Abbott Laboratories
• Active Biotech
• Amgen
• Argos Therapeutics
• ArQule
• AVEO Pharmaceuticals
• Bionomics
• Bristol-Myers Squibb
• Cerulean Pharma
• Exelixis
• Genentech
• immatics biotechnologies
• Immunicum
• Ono Pharmaceutical
• Onyx Therapeutics
• Oxford BioMedica
• Prometheus Laboratories
• Seattle Genetics
• Taiwan Liposome
• TRACON Pharmaceuticals
• Wilex
Market Driver
• Increase in Patient Population
• For a full, detailed list, view our report
Market Challenge
• High Cost of Drugs
• For a full, detailed list, view our report
Market Trend
• Strategic Alliances
• For a full, detailed list, view our report
Key Questions Answered in this Report
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
Complete Report Details @ https://www.wiseguyreports.com/reports/69824-global-kidney-cancer-drugs-market-2015-2019
Table of Contents
Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Product Profiles
05.1.1 Nexavar
05.1.2 Avastin
05.1.3 Votrient
05.1.4 Afinitor/Votubia
05.1.5 Proleukin
05.1.6 Inlyta
05.1.7 Sutent
05.1.8 Torisel
06. Introduction
07. Disease Overview
07.1 Understanding the Disease
07.1.1 Types of Kidney Cancer
07.1.2 Benign Kidney Tumors
07.2 Risk Factors
07.2.1 Lifestyle and Job-related Risk Factors
07.2.2 Genetic and Hereditary Risk Factors
07.2.3 Other Risk Factors
07.3 Etiology and Pathogenesis
07.3.1 Inherited Gene Mutations
07.3.2 Acquired Gene Mutations
07.4 Signs and Symptoms
07.5 Diagnosis
07.5.1 Medical History and Physical Exam
07.5.2 Lab Tests
07.5.3 Imaging Tests
07.5.4 Biopsy
07.6 Staging
07.6.1 TNM Staging System
07.7 Management
07.7.1 Surgery
07.7.2 Ablation and Other Local Therapies
07.7.3 Radiation Therapy
07.7.4 Targeted Therapy
07.7.5 Biologic Therapy (Immunotherapy)
07.7.6 Chemotherapy
07.8 Epidemiology
07.9 Economic Burden
08. Pipeline Analysis
08.1 Key Information on Pipeline Candidates
08.1.1 AGS-003
08.1.2 Rencarex
08.1.3 Cometriq
08.1.4 IMA901
08.1.5 AV-951
08.1.6 TroVax
08.1.7 MPDL3280A
08.1.8 Opdivo
08.1.9 Naptumomab Estafenatox
08.1.10 Carfilzomib
09. Market Landscape
09.1 Market Overview
09.2 Market Size and Forecast
09.3 Five Forces Analysis
10. Market Segmentation by Molecule Type
10.1 Small Molecules
10.2 Biologics
11. Geographical Segmentation
12. Buying Criteria
13. Market Growth Drivers
14. Drivers and Their Impact
15. Market Challenges
16. Impact of Drivers and Challenges
17. Market Trends
18. Trends and Their Impact
19. Vendor Landscape
19.1 Competitive Scenario
19.1.1 Key News
19.1.2 Mergers and Acquisitions
19.2 Market Share Analysis 2014
19.2.1 Bayer
19.2.2 F. Hoffmann-La Roche
19.2.3 GlaxoSmithKline
19.2.4 Novartis
19.2.5 Pfizer
19.3 Other and Future Prominent Vendors
20. Global Kidney Cancer Drugs Market: Key Takeaways
21. Key Vendor Analysis
21.1 Bayer
21.1.1 Key Facts
21.1.2 Business Overview
21.1.3 Business Segmentation by Revenue 2014
21.1.4 Business Segmentation by Revenue 2013 and 2014
21.1.5 Geographical Segmentation by Revenue 2014
21.1.6 Business Strategy
21.1.7 Recent Developments
21.1.8 SWOT Analysis
21.2 F. Hoffmann-La Roche
21.2.1 Key Facts
21.2.2 Business Overview
21.2.3 Business Segmentation
21.2.4 Business Segmentation by Revenue 2012 and 2013
21.2.5 Sales by Geography
21.2.6 Business Strategy
21.2.7 Key Information
21.2.8 SWOT Analysis
21.3 GlaxoSmithKline
21.3.1 Key Facts
21.3.2 Business Overview
21.3.3 Business Segmentation by Revenue 2014
21.3.4 Business Segmentation by Revenue 2013 and 2014
21.3.5 Geographical Segmentation by Revenue 2014
21.3.6 Business Strategy
21.3.7 Recent Developments
21.3.8 SWOT Analysis
21.4 Novartis
21.4.1 Key Facts
21.4.2 Business Description
21.4.3 Business Segmentation
21.4.4 Revenue by Business Segmentation
21.4.5 Revenue Comparison 2012 and 2013
21.4.6 Sales by Geography
21.4.7 Business Strategy
21.4.8 Key Developments
21.4.9 SWOT Analysis
21.5 Pfizer
21.5.1 Key Facts
21.5.2 Business Overview
21.5.3 Business Segmentation by Revenue 2014
21.5.4 Business Segmentation by Revenue 2013 and 2014
21.5.5 Geographical Segmentation by Revenue 2014
21.5.6 Business Strategy
21.5.7 Key Developments
21.5.8 SWOT Analysis
22. Other Reports in This Series
Continued…….
Buy This Report @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=69824
CONTACT US:
NORAH TRENT
Partner Relations & Marketing Manager
sales@wiseguyreports.com
www.wiseguyreports.com
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)
ABOUT US:
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories.
ADDRESS:
WISE GUY RESEARCH CONSULTANTS PVT LTD
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar
Pune - 411028
Maharashtra, India
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Kidney Cancer Drugs 2017 Global Market Expected to Grow at CAGR 7.36% and Forecast to 2019 here
News-ID: 497643 • Views: …
More Releases from wiseguyreports
Quality Management System Software Market to Reach USD 20.8 Billion by 2032 | Ex …
Quality Management System Software Market Overview:
The Quality Management System Software Market Industry is expected to grow from 9.88(USD Billion) in 2024 to 20.8 (USD Billion) by 2032. The Quality Management System Software Market CAGR (growth rate) is expected to be around 9.76% during the forecast period (2025 - 2032). The Quality Management System (QMS) Software Market has seen robust growth, driven by the increasing need for organizations to ensure compliance…
Video Game Development Software Market is Set to Achieve USD 12.45 Billion by 20 …
Video Game Development Software Market Overview:
The Video Game Development Software Market Industry is expected to grow from 9.23(USD Billion) in 2024 to 12.45 (USD Billion) by 2032. The Video Game Development Software Market CAGR (growth rate) is expected to be around 3.82% during the forecast period (2025 - 2032). The video game development software market is a cornerstone of the gaming industry, providing developers with the tools to create interactive…
Online Learning Management Systems Market is Expected to Touch USD 44.5 Billion …
Online Learning Management Systems Market Overview:
The Online Learning Management Systems Market Industry is expected to grow from 20.96(USD Billion) in 2024 to 44.5 (USD Billion) by 2032. The Online Learning Management Systems Market CAGR (growth rate) is expected to be around 9.86% during the forecast period (2025 - 2032). The Online Learning Management Systems (LMS) market has witnessed remarkable growth in recent years, driven by the increasing adoption of e-learning…
Virtual Webcam Market Poised for Explosive Growth, Reaching USD 41.6 Billion by …
Virtual Webcam Market Overview:
The Virtual Webcam Market Industry is expected to grow from 10.15(USD Billion) in 2024 to 41.6 (USD Billion) by 2032. The Virtual Webcam Market CAGR (growth rate) is expected to be around 19.29% during the forecast period (2025 - 2032). The virtual webcam market is experiencing rapid growth, fueled by increasing demand for remote communication tools, video conferencing, and content creation. Virtual webcams, which simulate camera feeds…
More Releases for Business
Business-to-Business eCommerce Market is Going to Boom | Alibaba, Amazon Busines …
The Global Business-to-Business eCommerce Market report, spanning over 135+ pages, provides a comprehensive overview of the product/industry scope and outlines the market outlook and status from 2024 to 2032. The study is segmented by key regions driving market growth. Currently, the market is expanding its presence, with notable contributions from key players such as Alibaba, Amazon Business, eBay Business, IndiaMART, ThomasNet, Global Sources, SAP Ariba, Salesforce, Shopify Plus, BigCommerce, Oracle…
Factors Influencing Global Business Broker Service Market through 2023 and Beyon …
The worldwide "Business Broker Service Market" 2023 Research Report presents a professional and complete analysis of the Global Business Broker Service Market in the current situation. This report includes development plans and policies along with Business Broker Service manufacturing processes and price structures. the reports 2023 research report offers an analytical view of the industry by studying different factors like Business Broker Service Market growth, consumption volume, Market Size, Revenue,…
Business Consulting Company, Business Consulting Firm, Business Consulting Servi …
The market research is an essential portion of any business strategy and primarily comprises of the data collecting about the markets and consumers in those markets. In recent’s globalized business surroundings, effective market research is a critical portion of any business’s efforts to compete successfully.
At Ken Research, the market research services support businesses identify growth opportunities and form a competitive strategy reliant on the deep understanding of consumers and…
Business to Business Media Market 2019 Business Scenario – Bloomberg, IBM, Ora …
A new Profession Intelligence Report released by Stats and Reports with the title Global Business to Business Media Market "can grow into the most important market in the world that has played an important role in making progressive impacts on the global economy. Global Business to Business Media Market Report presents a dynamic vision to conclude and research market size, market hope and competitive environment. The study is derived from…
Business Alliance Market Growing Dynamically with Leading Top Key Players like B …
A business alliance is an agreement between businesses, usually motivated by cost reduction and improved service for the customer. Alliances are often bounded by a single agreement with equitable risk and opportunity share for all parties involved and are typically managed by an integrated project team. An example of this is code sharing in airline alliances.
The Global Business Alliance Market 2019 research provides a basic overview of the industry including…
Global Interferon Market Business Growth, Business Opportunities, Business Outlo …
Albany, NY, USA / 16 Oct 2018: - A New fresh research report presented by KD Market Insights provides a detailed analysis of “Global Interferon Market Size, Trends, Opportunity and Forecast to 2023” research report will include all the major trends and technologies that play an important role in market growth in the predicted span of 6 years. It also presents the overview of industry players, advantages, challenges the business…
